DIGITAL PATHOLOGY MARKET ANALYSIS

Digital Pathology Market, by Product Type (Image Analysis Software, Scanner {Bright Field Scanner, Fluorescence Scanner}, Services {Installation & Integration, Maintenance Services, Consulting Services}), by Therapeutic Area (Oncology, Hematology, Autoimmune Disorder, Dermatology and Others), by Technology (Immunohistochemistry, ISH & FISH, Immunofluorescence and others) End User (Pharmaceutical & Biotechnology Companies, Diagnostic Labs, Hospital Laboratories, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)

Published In : May 2023
Code : CMI379
Pages :240
Formats :
Excel and PDF
Industry : Medical Devices

Regional Analysis

Global Digital Pathology Market - Regional Analysis

Among regions, North America is expected to dominate the market over the forecast period. The key drivers that are expected to propel the North America digital pathology market growth include the need for improving efficiency and accuracy of pathological diagnosis alongside the higher demand for remote work. As stated by Margaretta Colangelo, an advisory board member of the AI Precision Health Institute at the University of Hawaiʻi Cancer Center, in May 2022, the number of pathologists in North America is 4X less than what is needed on a global scale.

Europe is expected to hold second position in Global Digital Pathology Market over the forecast period. Europe is among the early adopters of digital pathology. One of the key drivers of its adoption in the region is that digital pathology supports collaborative research. Digital pathology provides access to large datasets & pathological images even from remote locations. This has encouraged several organizations to collaborate for adoption of a common digital platform. For instance, in 2020, the Deutsches Krebsforschungszentrum (DKTK) also known as the German Cancer Consortium, launched a Joint Imaging Platform (JIP) in the radiology and nuclear medicine departments of 10 university hospitals in Germany for feasible and shared analysis of pathological images.

North America: U.S. and Canada
Latin America: Brazil, Argentina, Mexico, and Rest of Latin America
Europe: Germany, U.K., Spain, France, Italy, Russia, and Rest of Europe
Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific
Middle East: GCC Countries, Israel, and Rest of Middle East
Africa: South Africa, North Africa, and Central Africa